Pharma company ranking based on market influence in developing countries 2018

This statistic depicts the pharmaceutical company ranking based on public policy and market influence in developing countries in 2018, according to the Access to Medicine Index. In that year, the company with the highest score in public policy and market influence in these countries was GlaxoSmithKline, scoring 4.01 points. The Access to Medicine Index is an independent initiative that ranks the world’s 20 largest companies according to their efforts to make their products more available, affordable and accessible in developing countries, highlighting policy and practice that either facilitate or hinder access to medicine.